SCHEMBL24258255

SCHEMBL24258255

FCC1CCC(CNc2ncnc(N(Cc3ccc(C(F)(F)F)cc3)C3CC3)c2F)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.41
CYP3A4 P08684 1/20 0.36
RPS6KB1 P23443 3/20 0.36
AURKA O14965 2/20 0.36
AURKB Q96GD4 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAP4K4 O95819 1/20 0.34
EGFR P00533 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.33
MDM2 Q00987 1/20 0.33
CCRL2 O00421 3/20 0.33
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
CRHR1 P34998 1/20 0.33
CSF1R P07333 1/20 0.33
LIPC P11150 1/20 0.32
LIPG Q9Y5X9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19640414 0.91 RORC (0.40) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19640730 0.89 CSF1R (0.43) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL30471947 0.89 SLC6A2 (0.40) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL23545680 0.89 SLC6A2 (0.40) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19640456 0.89 RORC (0.41) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19640665 0.89 RORC (0.39) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19650791 0.89 RORC (0.41) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19640602 0.88 RORC (0.43) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19640486 0.87 RORC (0.39) RORCCYP3A4RPS6KB1AURKAAURKB
SCHEMBL19650874 0.85 RORC (0.39) RORCCYP3A4MEN1KMT2AMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed